Article Per Year (5 Year)
p-Index From 2021 - 2026
2.133
P-Index
This Author published in this journals
All Journal Jurnal Farmasi dan Sains Indonesia (JFSI) PROFICIO: Jurnal Pengabdian Masyarakat Jurnal Pengabdian Masyarakat (ABDIRA) JUMANTIK (Jurnal Ilmiah Penelitian Kesehatan) Indonesian Journal on Medical Science (IJMS) Jurnal Farmasi Indonesia Jurnal Sains dan Kesehatan
Sawal, Rizky Ardian Hartanto
Sekolah Tinggi Ilmu Farmasi Nusaputera
Aerospace Engineering Agriculture, Biological Sciences & Forestry Humanities Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Computer Science & IT Education Environmental Science Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Medicine & Pharmacology Neuroscience Nursing Public Health Social Sciences Other

Published : 11 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 11 Documents
Search

 1   2 
Investigasi Potensi Antiviral Ekstrak Biji Kopi Robusta Temanggung Dalam Menghambat Virus Dengue (DENV) Sawal, Rizky Ardian Hartanto; Solichah, Ayu Ina; Puspitasari, Ismi; Daiman, Felina
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol 17 No 2 (2025): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35617/jfionline.v17i2.883

Abstract

Dengue Hemorrhagic Fever (DHF) is a significant health issue in tropical and subtropical regions. The discovery of new antiviral agents is crucial due to the lack of effective treatment or vaccines. This study aims to explore the potential of Temanggung robusta coffee bean extract as an anti-DENV agent. The coffee beans were extracted through maceration using 96% ethanol, followed by phytochemical screening to identify active compounds such as alkaloids, flavonoids, saponins, and tannins. Anti-DENV activity and Vero cell cytotoxicity tests were conducted to evaluate the extract's effectiveness and safety. Results indicated that robusta coffee extract exhibited anti-DENV activity with an EC50 of 88.51 µg/ml and a Selectivity Index (SI) of 9.82. The antiviral activity is attributed to bioactive compounds like alkaloids, flavonoids, saponins, and tannins that inhibit DENV replication. Although the extract demonstrated cytotoxicity at high concentrations with CC50 of 869.7 µg/ml, it still holds potential as a therapeutic anti-DENV agent with relatively low toxicity risks. This research opens opportunities for developing robusta coffee-based therapies for DENV infection control in the future.
Co-Authors Agustina Putri Pitarisa Agustina Putri Pitarisa Anastasia Eka Pratiwi Atalia Tamo Ina Bulu Auliya, Fitri Ayu Ina Solichah Bulu, Atalia Tamo Ina Daiman, Felina Dwi Wulandari Ferika Indrasari Ferika Indrasari Fitri Auliya Jason Merari Peranginangin Kamila, Iffa M Fatchur Rochman Margareta Retno Priamsari Metrikana Novembrina Muhammad Ikhsan Noel Asri Rahayu Pitarisa, Agustina Putri Pratiwi, Anastasia Eka Priamsari, Margaretha Retno Puspitasari, Ismi Rahayu, Noel Asri Reslely Harjanti Solichah, Ayu Ina Sri Suwarni Windarsih Sutrisna Windarsih Sutrisna Yahya Febrianto Yithro Serang